Most people with stage 5 kidney failure who forgo dialysis survive roughly six months to two years, though the range is wide. A systematic review of prognosis studies found median survival with conservative management spanning from about six to 23 months, while a larger meta-analysis reported a range of six to 31 months depending on the study population and how survival was measured. These numbers depend heavily on age, other health conditions, and how quickly kidney function was already declining before stage 5 was reached. For some older adults with serious comorbidities, the gap between dialysis and no dialysis narrows considerably, and the decision becomes less about adding years and more about how those remaining months are spent.
What the Survival Data Actually Show
Stage 5 kidney failure means the kidneys are filtering at less than 15 percent of normal capacity. Without some form of replacement therapy, waste products and fluid build up in the body, eventually causing life-threatening complications. But “without dialysis” does not mean “without treatment.” Conservative kidney management involves active medical care: controlling blood pressure, managing anemia, adjusting medications, treating symptoms, and slowing further decline where possible. The survival figures below reflect people receiving that kind of supportive care, not people who simply stopped seeing a doctor.
A systematic review published in the Journal of Palliative Medicine found that conservative management resulted in median survival of at least six months, with individual study medians ranging from about six to 23 months.1PubMed Central. Conservative Management of End-Stage Renal Disease without Dialysis: A Systematic Review A more recent meta-analysis that pooled data from multiple studies found the unadjusted median survival for conservative care ranged from six to 31 months, compared with 20 to 67 months for patients who chose dialysis.2PubMed Central. Survival of patients who opt for dialysis versus conservative care: a systematic review and meta-analysis That meta-analysis, which combined adjusted results from a dozen studies, estimated that patients who chose dialysis had roughly half the mortality risk of those who chose conservative care.
Those are averages across study populations, and individual outcomes scatter widely around them. Some people live three years or more without dialysis. Others, particularly those who reach stage 5 while already very ill with other conditions, may survive only weeks to a few months. The median tells you the midpoint, not the ceiling or the floor.
Who Tends to Live Longer Without Dialysis
Several factors consistently predict longer survival among people managed conservatively. A study of elderly patients with chronic kidney disease managed without dialysis found that younger age (within the elderly range), higher serum albumin levels, and kidney function that had not yet dropped below the 15 mark were all associated with better survival.3PubMed Central. CKD in elderly patients managed without dialysis: survival, symptoms, and quality of life Serum albumin is a protein in the blood, and low levels typically signal poor nutrition or chronic inflammation, both of which worsen outcomes in kidney failure.
The rate of kidney decline before reaching stage 5 matters too, though it is surprisingly hard to measure well. A narrative review in Kidney Medicine noted that most studies on conservative management did not track how fast kidney function was dropping, making it difficult to separate patients on a slow trajectory from those declining rapidly.4PubMed Central. Survival of Older Patients With Advanced CKD Managed Without Dialysis: A Narrative Review That same review flagged a measurement problem: frail elderly patients who lose muscle mass can appear to have stable kidney function on blood tests because creatinine, the molecule used to estimate kidney filtering, is produced by muscles. Less muscle means less creatinine, which can make the kidneys look better than they actually are.
Heart health is another major factor. As kidney function declines, the proportion of deaths caused by cardiovascular disease rises sharply. In a large study examining over 81,000 deaths, cardiovascular disease was the most common cause of death for anyone with kidney function below 60 percent of normal, and the share of deaths from heart failure specifically increased at every lower tier of kidney function.5PubMed Central. Cause of Death in Patients with Reduced Kidney Function This helps explain why people with existing heart disease tend to have shorter survival with or without dialysis.
When Dialysis May Not Add Much Time
The assumption that dialysis always buys significant extra time is one of the most common misconceptions about stage 5 kidney failure. For younger, otherwise healthy patients, dialysis clearly extends life by years. But for older adults and those with multiple serious health problems, the picture is murkier than most people expect.
The systematic review in the Journal of Palliative Medicine concluded that findings were mixed on whether dialysis prolongs survival in the elderly compared to conservative management, and that any survival benefit from dialysis shrinks as comorbidities increase, particularly ischemic heart disease.1PubMed Central. Conservative Management of End-Stage Renal Disease without Dialysis: A Systematic Review A separate systematic review found that for patients aged 80 and older and for elderly individuals with comorbidities, results were ambiguous, while conservative management seemed advantageous for quality of life.6PubMed Central. Does conservative kidney management offer a quantity or quality of life benefit compared to dialysis? A systematic review
One study put particularly stark numbers on this. It found that while dialysis patients had better early survival, the hazard rates crossed after a few months, meaning that past that crossing point, the conservatively managed patients were no longer dying faster. For a 65-year-old woman, the time to equal risk was about three months; for a 95-year-old patient of either sex, it was about one month.7PLoS ONE. Survival analysis of conservative vs. dialysis treatment of elderly patients with CKD stage 5 In other words, the older and sicker the patient, the faster dialysis lost its survival advantage. After the crossing point, there was actually a nonsignificant trend toward better survival in the conservative group.
This does not mean dialysis is pointless for the elderly. The meta-analysis pooling adjusted hazard ratios still found a statistically significant reduction in mortality risk for dialysis patients even in subgroups with older age or severe comorbidities.2PubMed Central. Survival of patients who opt for dialysis versus conservative care: a systematic review and meta-analysis But those subgroup analyses were based on unadjusted data, which means they did not account for the healthier patients being more likely to choose dialysis in the first place. This is a persistent limitation in the research: people who opt for conservative care tend to be sicker at baseline, making a fair comparison difficult. Randomized trials, which would solve this problem, have never been conducted because randomly assigning people to forgo a life-sustaining treatment raises obvious ethical barriers.
What Conservative Kidney Management Involves
Choosing not to start dialysis is sometimes described as “doing nothing,” but that framing is inaccurate and can lead to worse care. Conservative kidney management is an active treatment plan. It typically includes blood pressure control, management of fluid overload with diuretics, treatment of anemia, correction of bone and mineral imbalances, dietary adjustments, and symptom-focused medications for issues like nausea, itching, and pain.
Diet plays a meaningful role. A low-protein diet can slow the buildup of waste products that the kidneys can no longer clear. A cost-utility analysis of supplemented low-protein diets in patients with advanced kidney disease found that adding amino acid supplements to a restricted-protein diet improved survival by up to about half a year and delayed dialysis initiation by up to nearly three years compared to a standard low-protein diet.8PubMed Central. Ketoanalogue-Supplemented Low-Protein Diet in Patients with Stage 4+ Chronic Kidney Disease in Italy: A Cost–Utility Analysis Dietary interventions are most useful earlier in the trajectory, before kidney function drops to its lowest levels, but they remain part of the toolkit in conservative management.
Palliative care is the other major component, and it is often underutilized. Palliative care focuses on symptom relief and quality of life, and it can be delivered alongside active medical treatment at any stage of illness. A review in Clinical Medicine noted a recognized need to provide palliative care services for patients with advanced kidney disease and that such services can improve end-of-life care for those choosing not to have dialysis.9PubMed Central. Palliative and end-of-life care in advanced renal failure In practice, however, many kidney patients are referred to palliative care late or not at all, partly because of a persistent misconception that palliative care is the same as hospice and means “giving up.”
Quality of Life on Conservative Care Versus Dialysis
If the survival difference is modest, especially for older adults, then quality of life becomes the decisive factor for many patients. The research here offers a slightly counterintuitive finding. A systematic review comparing quality of life between the two paths found that physical health outcomes were worse in patients who chose conservative care compared with those who had chosen dialysis but had not yet started it. However, once dialysis actually began, physical health outcomes between the two groups looked similar.10PubMed. Health-related quality of life and symptoms of conservative care versus dialysis in patients with end-stage kidney disease: a systematic review Mental health was comparable across the board, whether patients chose conservative care or dialysis, before or after dialysis started.
What drags down quality of life differs between the two groups. For conservatively managed patients, the biggest independent predictors of poor self-rated health were difficulty performing usual activities, drowsiness, and shortness of breath. For dialysis patients, the main predictors were reduced ability to care for themselves and lack of energy.11PubMed Central. Factors associated with quality of life in patients with kidney failure managed conservatively and with dialysis: a cross-sectional study In other words, both paths impose heavy symptom burdens. Conservative care tends to involve more breathlessness and sleepiness, while dialysis tends to involve more exhaustion and loss of independence, partly because of the time commitment of treatment sessions.
One consistent finding is that conservative management patients spend fewer days in the hospital and are more likely to die at home. A retrospective study found that patients on the conservative pathway had four times the odds of dying outside of a hospital compared to dialysis patients.12PubMed Central. Understanding patterns and factors associated with place of death in patients with end-stage kidney disease: A retrospective cohort study For many patients and families, dying at home rather than in a hospital setting is a high priority, and conservative management makes that more achievable.
Symptoms in the Final Month
Understanding what the last weeks look like can help patients and families prepare, and this is an area where the research is remarkably detailed. A study that tracked symptoms in the month before death for stage 5 patients managed without dialysis found extremely high rates of distressing symptoms. More than 80 percent of patients experienced lack of energy, itching, drowsiness, and shortness of breath. About three-quarters had poor concentration and pain. Roughly 70 percent had poor appetite, swelling of the arms or legs, and dry mouth. More than half experienced constipation and nausea.13Journal of Pain and Symptom Management. Symptoms in the Month Before Death for Stage 5 Chronic Kidney Disease Patients Managed Without Dialysis
The level of distress from each symptom generally tracked its prevalence, with one exception: shortness of breath caused disproportionately more distress than its frequency alone would suggest. This matters for care planning because it means breathlessness should be aggressively managed even when other symptoms seem more prominent. Opioids, positioning, and sometimes supplemental oxygen can help, and a palliative care team experienced in kidney failure can make a significant difference in comfort during this phase.
The final days of untreated kidney failure typically involve increasing drowsiness, reduced consciousness, and a gradual decline rather than a sudden crisis. Uremic toxins build up, appetite drops to nothing, and the body slowly shuts down. Many families describe this as a relatively peaceful process when symptoms are well managed, though that “when” carries a lot of weight. Without proactive symptom control, the experience can involve severe restlessness, itching, and breathlessness.
Making the Decision and What Families Should Know
The choice between dialysis and conservative management is one of the most consequential medical decisions a patient can face, and the research on how patients experience that decision is worth knowing about. A scoping review found that patients who chose conservative care were generally satisfied with their choice and felt adequately informed at the time they made it. They reported that decision-making could have been improved by receiving information about all treatment options earlier and having it tailored to their individual situation. Some patients who felt pressured into choosing conservative care were unhappy at the time, though this was a minority. Higher levels of shared decision-making were associated with being better informed, greater satisfaction with care, and more certainty about the decision.14PubMed Central. Choosing conservative care in advanced chronic kidney disease: a scoping review of patients’ perspectives
The decision is rarely made by the patient alone. A narrative review examining the perspectives of different stakeholders found that caregivers play an important and influential role in the decision between conservative management and dialysis. Caregiver burden is high in both pathways and tends to increase over time. Interestingly, one study found that the care-related quality of life was actually worse for caregivers of people on dialysis compared to caregivers of people managed conservatively, even though overall health-related quality of life between the two caregiver groups was comparable.15PubMed Central. Deciding between conservative kidney management and dialysis in older people with kidney failure: a narrative review The review emphasized that better communication with and education for caregivers could help reduce anxiety around the decision.
It is also worth knowing that choosing conservative care is not an irreversible commitment. Patients can change their minds and start dialysis later, though starting dialysis as an emergency when someone is already very ill carries higher risks than a planned start. Likewise, patients who begin dialysis can later decide to stop, a situation that raises its own set of medical and emotional considerations but is a recognized and supported option in nephrology practice.
Predicting Survival for a Specific Person
Population-level medians are useful as a starting point, but what most patients and families want to know is how long this particular person is likely to live. Clinicians use a combination of lab values, functional status, and clinical judgment, but formal prognostic tools are still evolving. A recent international study found that the Framingham Risk Score, originally developed to predict heart attacks, was a valid tool for estimating mortality risk in patients with kidney failure, and that adding kidney-specific risk factors on top of it did not meaningfully improve predictions.16PubMed Central. Applicability of the Framingham Risk Score in predicting mortality among kidney failure patients: an international analysis This makes sense given that cardiovascular disease is the leading killer in this population.
In practice, though, no prognostic tool perfectly captures the individual case. A person with stage 5 kidney failure whose kidneys have been declining slowly over years, who still walks independently and eats well, occupies a very different prognostic space than someone who crashed into stage 5 over a few months, is bedbound, and has poorly controlled diabetes and heart failure. The first patient might reasonably expect a year or more on conservative management. The second might have weeks. Asking the nephrologist “what would you expect for someone like me?” is often more informative than any calculator, because the clinician can weigh factors that no single formula captures.
Withdrawing From Dialysis Versus Never Starting
It is common to conflate two different situations: never starting dialysis and stopping dialysis after having been on it. The trajectories differ. A patient who has been receiving dialysis and then withdraws typically has a shorter remaining survival window, often measured in days to a couple of weeks, because their body has been relying on the machine to clear waste. The buildup of toxins after withdrawal is faster than in someone whose body has been gradually adapting to declining kidney function over months or years.
A national Veterans Affairs cohort study compared clinical characteristics and outcomes between veterans treated with conservative management and those on dialysis. A greater proportion of deaths were observed among the dialysis group, though this likely reflects the longer follow-up time and different baseline characteristics rather than dialysis itself being harmful.17Nephrology Dialysis Transplantation. MO345: Clinical Characteristics and Trajectory in a National Cohort of Veterans Treated With Conservative Management Versus Dialysis The key point is that never-started and stopped-after-starting are different clinical situations with different expected timelines, and families should be aware of which scenario applies when interpreting survival estimates.
For patients who do withdraw from dialysis, the final days tend to follow a more compressed version of the same symptoms seen in conservative management: rising drowsiness, reduced appetite, fluid retention, and eventual loss of consciousness. Hospice teams experienced with renal patients can manage this transition effectively, and many dialysis units now have formal protocols for supporting patients through withdrawal.